ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025
[Pathological characteristics and diagnostic criteria of autoimmune hepatitis].
Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Autoimmune hepatitis (AIH) is a kind of chronic inflammatory liver disease mainly characterized by hepatocellular damage. There is no gold standard for its diagnosis, and it still relies on liver histological examination. Pathological examination is indispensable in the differential diagnosis and disease assessment of AIH. This article systematically reviews the evolution of pathological diagnostic criteria for AIH since the introduction of the initial scoring system by the International AIH in 1993, moving from early-stage empirical descriptions to quantitative scoring systems and then to the ongoing advancement of the latest international consensus standards. The standardization and accuracy of pathological diagnosis have significantly improved; at the same time, it reflects that the role of pathology in diagnosing AIH has shifted from a traditional auxiliary role to a key role in definitive diagnosis. The core pathological features of AIH include interface hepatitis, lymphoplasmacytic infiltrate, and hepatocellular rosettes; however, none of which are specific. The scarcity of specialized professionals, insufficient diagnostic resources at the foundation level, and the high subjectivity of pathological evaluation are the primary factors promoting to the current challenges in the pathological diagnosis of AIH. Quantitative pathological assessment, digital pathology, artificial intelligence assistance, and other advancements could drive the development of pathological diagnosis in AIH in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.